152 related articles for article (PubMed ID: 37414199)
1. Targeting of HBP1/TIMP3 axis as a novel strategy against breast cancer.
Zhou Y; Zhang T; Wang S; Yang R; Jiao Z; Lu K; Li H; Jiang W; Zhang X
Pharmacol Res; 2023 Aug; 194():106846. PubMed ID: 37414199
[TBL] [Abstract][Full Text] [Related]
2. HBP1 promoter methylation augments the oncogenic β-catenin to correlate with prognosis in NSCLC.
Tseng RC; Huang WR; Lin SF; Wu PC; Hsu HS; Wang YC
J Cell Mol Med; 2014 Sep; 18(9):1752-61. PubMed ID: 24895061
[TBL] [Abstract][Full Text] [Related]
3. Transcription factor HBP1 is a direct anti-cancer target of transcription factor FOXO1 in invasive oral cancer.
Chan CY; Huang SY; Sheu JJ; Roth MM; Chou IT; Lien CH; Lee MF; Huang CY
Oncotarget; 2017 Feb; 8(9):14537-14548. PubMed ID: 28099936
[TBL] [Abstract][Full Text] [Related]
4. Suppression of Wnt signaling by the green tea compound (-)-epigallocatechin 3-gallate (EGCG) in invasive breast cancer cells. Requirement of the transcriptional repressor HBP1.
Kim J; Zhang X; Rieger-Christ KM; Summerhayes IC; Wazer DE; Paulson KE; Yee AS
J Biol Chem; 2006 Apr; 281(16):10865-75. PubMed ID: 16495219
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase-13 is a target gene of high-mobility group box-containing protein 1 in modulating oral cancer cell invasion.
Chan CY; Lin TY; Sheu JJ; Wu WC; Huang CY
J Cell Physiol; 2019 Apr; 234(4):4375-4384. PubMed ID: 30191992
[TBL] [Abstract][Full Text] [Related]
6. Alterations of the HBP1 transcriptional repressor are associated with invasive breast cancer.
Paulson KE; Rieger-Christ K; McDevitt MA; Kuperwasser C; Kim J; Unanue VE; Zhang X; Hu M; Ruthazer R; Berasi SP; Huang CY; Giri D; Kaufman S; Dugan JM; Blum J; Netto G; Wazer DE; Summerhayes IC; Yee AS
Cancer Res; 2007 Jul; 67(13):6136-45. PubMed ID: 17616670
[TBL] [Abstract][Full Text] [Related]
7. Transcription Factor HBP1 Enhances Radiosensitivity by Inducing Apoptosis in Prostate Cancer Cell Lines.
Chen Y; Wang Y; Yu Y; Xu L; Zhang Y; Yu S; Li G; Zhang Z
Anal Cell Pathol (Amst); 2016; 2016():7015659. PubMed ID: 26942107
[TBL] [Abstract][Full Text] [Related]
8. HBP1-mediated Regulation of p21 Protein through the Mdm2/p53 and TCF4/EZH2 Pathways and Its Impact on Cell Senescence and Tumorigenesis.
Chen Y; Pan K; Wang P; Cao Z; Wang W; Wang S; Hu N; Xue J; Li H; Jiang W; Li G; Zhang X
J Biol Chem; 2016 Jun; 291(24):12688-12705. PubMed ID: 27129219
[TBL] [Abstract][Full Text] [Related]
9. The tumor suppressor protein HBP1 is a novel c-myc-binding protein that negatively regulates c-myc transcriptional activity.
Escamilla-Powers JR; Daniel CJ; Farrell A; Taylor K; Zhang X; Byers S; Sears R
J Biol Chem; 2010 Feb; 285(7):4847-58. PubMed ID: 20008325
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA actin filament-associated protein 1 antisense RNA 1 promotes malignant phenotype through binding with lysine-specific demethylase 1 and repressing HMG box-containing protein 1 in non-small-cell lung cancer.
Yu S; Yang D; Ye Y; Liu P; Chen Z; Lei T; Pu J; Liu L; Wang Z
Cancer Sci; 2019 Jul; 110(7):2211-2225. PubMed ID: 31069893
[TBL] [Abstract][Full Text] [Related]
11. Cloning and expression of human HBP1, a high mobility group protein that enhances myeloperoxidase (MPO) promoter activity.
Lin KM; Zhao WG; Bhatnagar J; Zhao WD; Lu JP; Simko S; Schueneman A; Austin GE
Leukemia; 2001 Apr; 15(4):601-12. PubMed ID: 11368363
[TBL] [Abstract][Full Text] [Related]
12. Up-regulated NRIP2 in colorectal cancer initiating cells modulates the Wnt pathway by targeting RORβ.
Wen Z; Pan T; Yang S; Liu J; Tao H; Zhao Y; Xu D; Shao W; Wu J; Liu X; Wang Y; Mao J; Zhu Y
Mol Cancer; 2017 Jan; 16(1):20. PubMed ID: 28137278
[TBL] [Abstract][Full Text] [Related]
13. The expression of the tumour suppressor HBP1 is down-regulated by growth factors via the PI3K/PKB/FOXO pathway.
Coomans de Brachène A; Bollaert E; Eijkelenboom A; de Rocca Serra A; van der Vos KE; Burgering BM; Coffer PJ; Essaghir A; Demoulin JB
Biochem J; 2014 May; 460(1):25-34. PubMed ID: 24762137
[TBL] [Abstract][Full Text] [Related]
14. The HMG box transcription factor HBP1: a cell cycle inhibitor at the crossroads of cancer signaling pathways.
Bollaert E; de Rocca Serra A; Demoulin JB
Cell Mol Life Sci; 2019 Apr; 76(8):1529-1539. PubMed ID: 30683982
[TBL] [Abstract][Full Text] [Related]
15. The transcription factor HBP1 promotes ferroptosis in tumor cells by regulating the UHRF1-CDO1 axis.
Yang R; Zhou Y; Zhang T; Wang S; Wang J; Cheng Y; Li H; Jiang W; Yang Z; Zhang X
PLoS Biol; 2023 Jul; 21(7):e3001862. PubMed ID: 37406020
[TBL] [Abstract][Full Text] [Related]
16. All Trans-Retinoic Acid Mediates MED28/HMG Box-Containing Protein 1 (HBP1)/β-Catenin Signaling in Human Colorectal Cancer Cells.
Lee MF; Hsieh NT; Huang CY; Li CI
J Cell Physiol; 2016 Aug; 231(8):1796-803. PubMed ID: 26660958
[TBL] [Abstract][Full Text] [Related]
17. miR-17-5p promotes human breast cancer cell migration and invasion through suppression of HBP1.
Li H; Bian C; Liao L; Li J; Zhao RC
Breast Cancer Res Treat; 2011 Apr; 126(3):565-75. PubMed ID: 20505989
[TBL] [Abstract][Full Text] [Related]
18. Timp3 loss accelerates tumour invasion and increases prostate inflammation in a mouse model of prostate cancer.
Adissu HA; McKerlie C; Di Grappa M; Waterhouse P; Xu Q; Fang H; Khokha R; Wood GA
Prostate; 2015 Dec; 75(16):1831-43. PubMed ID: 26332574
[TBL] [Abstract][Full Text] [Related]
19. HMG-box transcription factor 1: a positive regulator of the G1/S transition through the Cyclin-CDK-CDKI molecular network in nasopharyngeal carcinoma.
He S; Yang S; Niu M; Zhong Y; Dan Gao ; Zhang Y; Ma H; Xiong W; Zhou M; Zhou Y; Xiang B; Li G; Shuai C; Peng S
Cell Death Dis; 2018 Jan; 9(2):100. PubMed ID: 29367693
[TBL] [Abstract][Full Text] [Related]
20. miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway.
Li W; Yi J; Zheng X; Liu S; Fu W; Ren L; Li L; Hoon DSB; Wang J; Du G
Clin Epigenetics; 2018; 10():64. PubMed ID: 29796115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
